Evidence map›Paper›PMID 20493260›Full record

ReviewNeurobiology of disease2010

Neurodegenerative disorders: insights from the nematode Caenorhabditis elegans.

Maria Dimitriadi, Anne C Hart

Open access · greenAbstract readReview
In one paragraph

Review in Neurobiology of disease, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Suppressing APOE4-induced neural pathologies by targeting the VHL-HIF axis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Frontiers in pharmacology · 2022
    Article
  10. Article
  11. Brain sciences · 2020
    Review
  12. Article
  13. Effects of NADBiomolecules · 2020
    Review
  14. Review
  15. Article
  16. Automated phenotyping and lifespan assessment of aTranslational medicine of aging · 2020
    Article
  17. Article
  18. Article
  19. Pasteurized Orange Juice Rich in Carotenoids ProtectsOxidative medicine and cellular longevity · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Maria DimitriadiDepartment of Neuroscience, Brown University, 185 Meeting Street, Providence, RI 02912, USA.
Anne C Hart
Brown University · US

Funding

C. ELEGANS MODEL FOR POLYGLUTAMINE TOXICITYR01NS040048 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI HART, ANNE CHURCH · 2001 to 2005
$1.7M
NINDS NIH HHS R01 NS040048
6 · The paper itself

Abstract

Neurodegenerative diseases impose a burden on society, yet for the most part, the mechanisms underlying neuronal dysfunction and death in these disorders remain unclear despite the identification of relevant disease genes. Given the molecular conservation in neuronal signaling pathways across vertebrate and invertebrate species, many researchers have turned to the nematode Caenorhabditis elegans to identify the mechanisms underlying neurodegenerative disease pathology. C. elegans can be engineered to express human proteins associated with neurodegeneration; additionally, the function of C. elegans orthologs of human neurodegenerative disease genes can be dissected. Herein, we examine major C. elegans neurodegeneration models that recapitulate many aspects of human neurodegenerative disease and we survey the screens that have identified modifier genes. This review highlights how the C. elegans community has used this versatile organism to model several aspects of human neurodegeneration and how these studies have contributed to our understanding of human disease.

Indexed as

AnimalsCaenorhabditis elegansDisease Models, AnimalGenetic Predisposition to DiseaseHumansNeurodegenerative Diseases

Identifiers

PMID20493260
PMCPMC2926245
OpenAlexW2076628540

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.